What Happened? A number of stocks fell in the afternoon session after the major pulled back (Nasdaq -1.3%, S&P 500 - 1.4%) as ...

Hims & Hers continues to deliver strong subscriber and revenue growth, with Q1 2025 revenue up 111% YoY. Check out why I ...

Looking back on healthcare technology stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including ...

After the the FDA declared an end to the shortage of GLP-1 medications, compounded versions of the drug must be out of the market by Thursday.

Hims & Hers delivered impressive Q1 2025 results, with 111% y/y revenue growth and 38% y/y subscriber growth. Check out why I ...

Following the company's first-quarter earnings report, shares of Hims & Hers Health (HIMS -1.88%) opened the following day ...

Online health and wellness company Hims & Hers raised $1 billion through convertible senior notes to grow its international ...

Hims & Hers, the telehealth and wellness company, has hired a veteran of the autonomous vehicle industry as its next chief ...

CEO Andrew Dudum said the funds will allow the company to grow internationally and invest in artificial intelligence.